AKERO THERAPEUTICS INC (AKRO) Stock Analyst Ratings
NASDAQ:AKRO - Nasdaq - US00973Y1082 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to AKRO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 66.61. This target is 18.35% above the current price.
AKRO was analyzed by 18 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about AKRO.
In the previous month the buy percentage consensus was at a similar level.
AKRO was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-31 | UBS | Maintains | Buy -> Buy |
| 2025-01-30 | B of A Securities | Upgrade | Neutral -> Buy |
| 2025-01-28 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-28 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-01-28 | Citigroup | Maintains | Buy -> Buy |
| 2025-01-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-18 | Citigroup | Initiate | Buy |
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-12 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-11 | Wolfe Research | Initiate | Outperform |
| 2024-06-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-05-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-22 | B of A Securities | Reiterate | Neutral |
| 2024-03-05 | UBS | Maintains | Buy -> Buy |
| 2024-03-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-12 | UBS | Maintains | Buy -> Buy |
| 2023-10-11 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-10-11 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-10-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-10-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-04 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |